Moderna Inc (MRNA)

[axelvento]

Vinay Prasad overruled the agency’s reviewers when he refused to accept Moderna’s application for a new influenza vaccine,

Three agency officials familiar with the matter that the team of career scientists was ready to review Moderna’s application, and that David Kaslow, the head of the vaccine office, wrote a detailed memo explaining why the FDA should embark on the review.